Anxiety symptoms were associated with a higher prevalence of metabolic syndrome (47.0% vs 31.9%), while depressive symptoms correlated with specific metabolic components depending on ethnic origin.
Cross-Sectional (n=1,637)
Are depressive and anxiety symptoms associated with metabolic syndrome and its components among diverse migrant origin populations?
Depressive and anxiety symptoms are associated with metabolic syndrome and its components, with variations in the strength of these associations across different migrant origin populations.
Tasa de eventos absoluta: 47% vs 31.9%
OBJECTIVE: Positive association of depressive and anxiety symptoms with the metabolic syndrome (MetS) have been reported, however there is little information on these among migrant origin populations. The aim of this study was to examine these associations among diverse migrant origin populations in Finland. METHODS: Data of 318 Russian, 212 Somali, and 321 Kurdish origin participants in the cross-sectional Finnish Migrant Health and Wellbeing Study (Maamu) aged 30-64 years was used. The general population reference group constituted of 786 Health 2011 Survey participants. Depressive and anxiety symptoms were measured with HSCL-25 subscales. Harmonized definition of MetS was used. RESULTS: Depressive symptoms were associated with elevated blood pressure in Kurdish origin (30.1%, 95% CI 22.7-38.8 vs. 19.9%, 95%CI 15.4-25.4 for those with and without symptoms respectively); and elevated waist circumference (72.1%, 95%CI 56.9-83.5 vs. 55.0%, 95%CI 50.6-59.4) and triglycerides (30.8%, 95%CI 16.0-51.0 vs. 11.9%, 95%CI 9.3-15.0) in general population. Anxiety symptoms were associated with MetS (47.0%, 95%CI 37.6-56.7 vs. 31.9%, 95%CI 26.7-37.6) and elevated blood pressure (37.2%, 95%CI 28.3-46.9 vs. 18.8%, 95%CI 14.7-23.6), and with elevated triglycerides in Somali origin (33.0%, 95%CI 14.5-59.0 vs. 5.7%, 95%CI 3.3-9.6) and general population (30.2%, 95%CI 16.4-48.8, 12.8%, 95%CI 9.9-16.2). No associations between low HDL-cholesterol and depressive or anxiety symptoms were observed. CONCLUSION: Cardiometabolic health should be taken into account in mental health services. Future studies should explore the underlying pathways to the observed differences in strengths of associations of depressive and anxiety symptoms with MetS and its components across diverse migrant origin populations.
Skogberg et al. (Tue,) conducted a cross-sectional in Metabolic syndrome (n=1,637). Depressive and anxiety symptoms vs. No depressive or anxiety symptoms was evaluated on Metabolic syndrome. Anxiety symptoms were associated with a higher prevalence of metabolic syndrome (47.0% vs 31.9%), while depressive symptoms correlated with specific metabolic components depending on ethnic origin.